Evidence map›Paper›PMID 29789535›Full record

ArticleNature communications2018

Coupling bimolecular PARylation biosensors with genetic screens to identify PARylation targets.

Dragomir B Krastev, Stephen J Pettitt, James Campbell, Feifei Song, Barbara E Tanos, Stoyno S Stoynov, Alan Ashworth, Christopher J Lord

Open access · goldAbstract read
In one paragraph

Article in Nature communications, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 24 papers.

0numbers the graph read from it
0cells of the map it votes in
24citing papers in PubMed
1.1field-weighted citation impact, top 19% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

24 citing papers in PubMed, 35 citations in OpenAlex.

  1. Review
  2. Review
  3. Article
  4. Article
  5. Article
  6. Poly-ADP-ribosylation dynamics, signaling, and analysis.Environmental and molecular mutagenesis · 2024
    Review
  7. Article
  8. Article
  9. Review
  10. Review
  11. Article
  12. Article
  13. Inhibitors of PARP: Number crunching and structure gazing.Proceedings of the National Academy of Sciences of the United States of America · 2022
    Article
  14. Article
  15. Article
  16. Article
  17. Discovery of a Novel Triazolopyridine Derivative as a Tankyrase Inhibitor.International journal of molecular sciences · 2021
    Article
  18. Article
  19. Genetically Encoded Fluorescent Sensor for Poly-ADP-Ribose.International journal of molecular sciences · 2020
    Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 2 institutions in 3 countries.

Dragomir B KrastevThe CRUK Gene Function Laboratory and Breast Cancer Now Toby Robins Research Centre, The Institute of Cancer Research, London, SW3 6JB, UK.
Stephen J PettittThe CRUK Gene Function Laboratory and Breast Cancer Now Toby Robins Research Centre, The Institute of Cancer Research, London, SW3 6JB, UK.ORCID http://orcid.org/0000-0003-3313-3857
James CampbellThe CRUK Gene Function Laboratory and Breast Cancer Now Toby Robins Research Centre, The Institute of Cancer Research, London, SW3 6JB, UK.
Feifei SongThe CRUK Gene Function Laboratory and Breast Cancer Now Toby Robins Research Centre, The Institute of Cancer Research, London, SW3 6JB, UK.
Barbara E TanosThe Cancer Therapeutics Division, The Institute of Cancer Research, London, SW3 6JB, UK.
Stoyno S StoynovThe Institute of Molecular Biology, Bulgarian Academy of Sciences, 1113, Sofia, Bulgaria.
Alan AshworthThe CRUK Gene Function Laboratory and Breast Cancer Now Toby Robins Research Centre, The Institute of Cancer Research, London, SW3 6JB, UK. Alan.Ashworth@ucsf.edu.
Christopher J LordThe CRUK Gene Function Laboratory and Breast Cancer Now Toby Robins Research Centre, The Institute of Cancer Research, London, SW3 6JB, UK. Chris.Lord@icr.ac.uk.
Institute of Cancer Research · GBBulgarian Academy of Sciences · BG

Funding

Translational InformaticsP30CA082103 · NCI · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI Jennifer Leigh Clarke · 1999 to 2026
$209.7M
Cancer Research UK 14276Cancer Research UK 24439NCI NIH HHS P30 CA082103
6 · The paper itself

Abstract

Poly (ADP-ribose)ylation is a dynamic protein modification that regulates multiple cellular processes. Here, we describe a system for identifying and characterizing PARylation events that exploits the ability of a PBZ (PAR-binding zinc finger) protein domain to bind PAR with high-affinity. By linking PBZ domains to bimolecular fluorescent complementation biosensors, we developed fluorescent PAR biosensors that allow the detection of temporal and spatial PARylation events in live cells. Exploiting transposon-mediated recombination, we integrate the PAR biosensor en masse into thousands of protein coding genes in living cells. Using these PAR-biosensor "tagged" cells in a genetic screen we carry out a large-scale identification of PARylation targets. This identifies CTIF (CBP80/CBP20-dependent translation initiation factor) as a novel PARylation target of the tankyrase enzymes in the centrosomal region of cells, which plays a role in the distribution of the centrosomal satellites.

Indexed as

Biosensing TechniquesMitosisProtein Processing, Post-TranslationalCalcium-Binding ProteinsCell Line, TumorCentriolesCentrosomeDNA Transposable ElementsEpithelial CellsEukaryotic Initiation FactorsFluorescent DyesGenetic TestingHeLa CellsHumansPoly Adenosine Diphosphate RibosePoly ADP RibosylationCalcium-Binding ProteinsCETN3 protein, humanCTIF protein, humanDNA Transposable ElementsEukaryotic Initiation FactorsFluorescent DyesPoly Adenosine Diphosphate RiboseTankyrasesTNKS2 protein, human

Identifiers

PMID29789535
PMCPMC5964205
OpenAlexW2804673542

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.